<p>安德鲁·布拉克曼因多种因素给予了 Quest Diagnostics 买入评级，这些因素突显了该公司的强劲表现和良好的前景。该公司在第三季度报告中交出了积极的业绩，超出了关键指标的预期。这一表现得益于多个有利趋势，包括使用率的提高、价格的稳定以及成功的并购。</p>
<p>Quest Diagnostics 还展示了令人印象深刻的有机收入增长，超出了市场共识预期。公司的调整后营业利润率和每股收益符合或高于预期，进一步巩固了其财务健康。此外，公司提高了全年业绩指引，显示出对持续增长的信心。这些因素共同证明了 Quest Diagnostics 股票的溢价估值，支持了买入评级。</p>
<p>在 10 月 17 日发布的另一份报告中，瑞穗证券也维持了该股票的买入评级，目标价为 210.00 美元。</p>

奎斯特诊疗

<p>安德鲁·布拉克曼对 Quest Diagnostics 给予了买入评级，理由是其第三季度业绩强劲，超出预期。主要驱动因素包括使用率增加、价格稳定以及成功的并购。该公司报告了令人印象深刻的有机收入增长，并上调了全年业绩指引，进一步巩固了其财务健康状况。瑞穗证券也维持了买入评级，目标价为 210 美元。这些因素支持了 Quest Diagnostics 股票的溢价估值</p>

<p>Andrew Brackmann has given his Buy rating due to a combination of factors that highlight Quest Diagnostics’ strong performance and promising outlook. The company delivered positive results in its third-quarter report, surpassing expectations across key metrics. This performance was driven by several favorable trends, including increased utilization, stable pricing, and successful mergers and acquisitions.</p>
<div class="lb-trans"><p>安德鲁·布拉克曼因多种因素给予了 Quest Diagnostics 买入评级，这些因素突显了该公司的强劲表现和良好的前景。该公司在第三季度报告中交出了积极的业绩，超出了关键指标的预期。这一表现得益于多个有利趋势，包括使用率的提高、价格的稳定以及成功的并购。</p>
</div><p>Quest Diagnostics also demonstrated impressive organic revenue growth, which exceeded consensus estimates. The company’s adjusted operating margin and earnings per share were in line with or above expectations, further solidifying its financial health. Additionally, the company raised its full-year guidance, indicating confidence in continued growth. These factors collectively justify the premium valuation of Quest Diagnostics’ shares, supporting the Buy rating.</p>
<div class="lb-trans"><p>Quest Diagnostics 还展示了令人印象深刻的有机收入增长，超出了市场共识预期。公司的调整后营业利润率和每股收益符合或高于预期，进一步巩固了其财务健康。此外，公司提高了全年业绩指引，显示出对持续增长的信心。这些因素共同证明了 Quest Diagnostics 股票的溢价估值，支持了买入评级。</p>
</div><p>In another report released on October 17, Mizuho Securities also maintained a Buy rating on the stock with a $210.00 price target.</p>
<div class="lb-trans"><p>在 10 月 17 日发布的另一份报告中，瑞穗证券也维持了该股票的买入评级，目标价为 210.00 美元。</p>
</div>

奎斯特诊疗：强劲的业绩表现和乐观的前景证明了买入评级的合理性